With hA5 CAR T cells producing the lowest levels of TNF, IFNγ, and GM-CSF, they may present a reduced risk of initiating or amplifying CRS while still maintaining cytotoxic efficacy. The gene discussed is TNF; the disease is congenital rubella syndrome.